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use was based on surgeons' preferences only. Vein size or patient factors (with the exception of a few patients in the early period who were excluded due to equipment failure or unsuitable vein) did not affect the choice of the procedure. The length of follow-up was 30 days postoperative. No patient appears to have been lost to follow-up.
Analysis of effectiveness
The analysis of effectiveness was conducted on all patients included in the initial study sample. The outcome measures used were: the rate of wound complications (Types I, II, III; haematoma, and seroma), the postoperative length of stay (LOS), the postoperative ankle-brachial index (ABI), the overall 30-day primary patency rate, the rate of patients who were re-explored acutely, the rate of readmission within 30 days, and primary patency and limb salvage rates.
The study groups were comparable at baseline in terms of demographics, risk factors, preoperative characteristics, and operative details. However, 18% of OPEN patients underwent in situ bypass versus none in the ENDO group, (p<0.005).
Effectiveness results
The overall rate of wound complications was 34.1% in the OPEN group and 20.4% in the ENDO group, (p<0.02).
The rate of Type I wound complications was 13.5% (OPEN) versus 11.2% (ENDO), (p non significant).
The rate of Type II wound complications was 15.9% (OPEN) versus 6.5% (ENDO), (p<0.03).
The rate of Type III wound complications was 4.8% (OPEN) versus 2.8% (ENDO), (p non significant).
The rate of haematoma was 8.7% (OPEN) versus 6.5% (ENDO), (p non significant).
The rate of seroma was 10.9% (OPEN) versus 6.4% (ENDO), (p non significant).
The mean postoperative LOS was 10.1 (+/-12.3) days (median 7; mode 7) in the OPEN group and 8.3 (+/-7.8) days (median 6; mode 3) in the ENDO group, (p<0.03). The overall 30-day primary patency rate was 91% in the OPEN group versus 92% in the ENDO group, (p non significant).
The rate of patients who were re-explored acutely was 0% in the OPEN group versus 2.8% in the ENDO group, (p non significant).
The rate of readmission within 30 days was 11.4% in the OPEN group versus 4.1% in the ENDO group.
Primary patency and limb salvage rates were not significantly different in the two groups.
Synthesis of costs and benefits
A synthesis of the costs and benefits was not relevant since a cost-consequences analysis was conducted.
Authors' conclusions
Endoscopic saphenous vein harvest (ENDO) for lower extremity bypass led to a reduction in the wound complication rate and costs, mainly due to reduced inpatient stay, in comparison with traditional open surgery.
CRD COMMENTARY -Selection of comparators
The choice of the comparator was appropriate as it reflected the traditional approach use for patients undergoing harvest of the greater saphenous vein for infrainguinal bypass. You should decide whether this is a valid comparator in your own setting.
Validity of estimate of measure of effectiveness
The analysis of effectiveness was based on a cohort study, which was conducted retrospectively. The patients' charts were retrospectively reviewed to identify eligible patients. The retrospective nature of the study limited the validity of the analysis, and no justification for the choice of sample size was provided. In fact, power calculations were not reported. The study groups were fairly comparable at baseline, which reduced the potential impact of confounding factors. The analysis considered all patients initially included in the study sample since no loss to follow-up was observed. The study sample appears to have been representative of the study population. The analysis had a short-term time horizon. The choice of the surgical approach was based on surgeons' preferences rather than on a random process. The authors noted that some bias could have been introduced, owing to the lack of randomisation and masking. In fact, surgeon preference could have affected the results of the study. These issues tend to limit the internal validity of the analysis.
Validity of estimate of measure of benefit
No summary benefit measure was used in the analysis because a cost-consequences analysis was conducted.
Validity of estimate of costs
The perspective of the study was not explicitly stated, although it appears to have been that of the hospital. A breakdown of the cost items was provided, although information on the unit costs and quantities of resources used was not presented. This limits the possibility of replicating the study. Statistical tests were conducted, but the authors acknowledged the limited power of the economic analysis due to the small sample size. The cost estimates were specific to the study setting and no sensitivity analyses were conducted. The price year was reported, which makes reflation exercises in other settings easy.
